GlaxoSmithKline strikes $300 million deal with 23andMe for genetics-driven drug research Life Science
Biogen and Eisai say Alzheimer’s treatment slowed disease progression, backing amyloid theory Life Science
Hillhouse Capital Leads $230M Series B Preferred Stock Financing In US Biopharmaceutical Firm Gossamer Bio Life Science
Pfizer Plans $465 Million Project in Michigan, Part of its $5 Billion Manufacturing Plan Life Science
Bristol-Myers Squibb and Tsinghua University Announce Collaboration to Accelerate Early Research into Potential Therapies for Autoimmune Diseases and Cancer Life Science
Resource Weekly 309 – London Metal Exchange moves further towards launch of lithium contract Energy, Mining
Agios Pharmaceuticals Scores FDA Approval For Tibsovo, Second AML Drug Win in Less Than a Year Life Science